Bay City Capital

Bay City Capital

Pulse 2.0

Iterum Therapeutics (ITRM) Stock: Why It Surged Over 20% Today

Pulse 2.0

Kezar Life Sciences (KZR) Stock: Why It Surged 43.43%

Pulse 2.0

Kezar Life Sciences (KZR) Stock: Why The Price Surged Today

Northstack

Oculis raises $57m Series C led by BVCF Management and Hyfinity Investments

$100,500,000 Venture capital (Series B)
FinSMEs , Pulse 2.0

Xilio Therapeutics Raises $100.5M in Series B Financing

Acquisition
Xconomy , FinSMEs

Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira

the home of AI info

Menlo Therapeutics Inc. (MNLO)'s Financial Results Comparing With Minerva Neurosciences Inc ...

Electric Shaver For Women Reviews

Tria Beauty Hair Removal Laser 4X Review

Silicon Canals

Swiss startup Oculis secures €13.8M funding to treat ophthalmic diseases

$15,711,870 Venture capital (Series B)
FinSMEs , PE HUB

Oculis Raises CHF15.5M in Extension of Series B Financing

$30,000,000 Venture capital (Series A)
FinSMEs , PE HUB , MedCity News , +1

Akrevia Therapeutics Raises $30M in Series A Financing

Funding Health
$75,000,000 IPO
PE HUB

VC-backed Kezar Life Sciences unveils IPO

Stock markets Health
Bloomberg

Dermira Reminds Investors What Binary Means in Biotech

Stock markets Health
Xconomy

Dermira Abandons Acne Drug After Phase 3 Flops, Stock Price Craters

Health
FinSMEs

Menlo Therapeutics Announces IPO Pricing

Stock markets Health
PE HUB

| Oculis nabs $20.3 mln Series B

Funding Health
$20,300,000 Venture capital (Series B)
Norðurskautið , FinSMEs

Oculis raises $20.3m Series B round to advance treatment for Ophthalmic Diseases

Funding Health
Xconomy

Dermira Commits $135M for Global Rights to Roche Eczema Drug

Health
$50,000,000 Venture capital (Series C)
FinSMEs , prnewswire

Menlo Therapeutics Raises $50M in Series C Financing

$65,000,000 Venture capital (Series B)
PE HUB

Iterum grabs $65 mln Series B

Messaging